GABELLI & Co INVESTMENT ADVISERS, INC. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI & Co INVESTMENT ADVISERS, INC. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$6,525
+226.2%
21,8960.0%0.00%
Q3 2022$2,000
-33.3%
21,8960.0%0.00%
Q2 2022$3,000
-25.0%
21,8960.0%0.00%
-100.0%
Q1 2022$4,000
-69.2%
21,8960.0%0.00%
-50.0%
Q4 2021$13,000
-7.1%
21,8960.0%0.00%0.0%
Q3 2021$14,00021,8960.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2022
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 13,333$132,0000.02%
Radcliffe Capital Management, L.P. 66,666$661,0000.02%
MARSHALL WACE, LLP 108,584$1,076,0000.00%
MMCAP International Inc. SPC 73,525$7,0000.00%
DIFESA CAPITAL MANAGEMENT, LP 14,159$1,0000.00%
WHITEBOX ADVISORS LLC 16,833$2,0000.00%
MILLENNIUM MANAGEMENT LLC 140,000$14,0000.00%
LINDEN ADVISORS LP 40,115$3,0000.00%
Calamos Advisors LLC 33,333$2,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 19,560$1,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders